DK2687518T3 - Nitrogenholdig mættet heterocyclisk forbindelse - Google Patents

Nitrogenholdig mættet heterocyclisk forbindelse

Info

Publication number
DK2687518T3
DK2687518T3 DK12757539.7T DK12757539T DK2687518T3 DK 2687518 T3 DK2687518 T3 DK 2687518T3 DK 12757539 T DK12757539 T DK 12757539T DK 2687518 T3 DK2687518 T3 DK 2687518T3
Authority
DK
Denmark
Prior art keywords
nitrogen
heterocyclic compound
saturated heterocyclic
containing saturated
useful
Prior art date
Application number
DK12757539.7T
Other languages
English (en)
Inventor
Toru Iijima
Hiroshi Sugama
Takayuki Kawaguchi
Jingkang Shen
Guangxin Xia
Jianshu Xie
Miki Hirai
Original Assignee
Mitsubishi Tanabe Pharma Corp
Shanghai Pharmaceuticals Holding Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Tanabe Pharma Corp, Shanghai Pharmaceuticals Holding Co Ltd filed Critical Mitsubishi Tanabe Pharma Corp
Application granted granted Critical
Publication of DK2687518T3 publication Critical patent/DK2687518T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK12757539.7T 2011-03-16 2012-03-15 Nitrogenholdig mættet heterocyclisk forbindelse DK2687518T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011058338 2011-03-16
PCT/JP2012/056750 WO2012124775A1 (ja) 2011-03-16 2012-03-15 含窒素飽和複素環化合物

Publications (1)

Publication Number Publication Date
DK2687518T3 true DK2687518T3 (da) 2018-01-29

Family

ID=46830839

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12757539.7T DK2687518T3 (da) 2011-03-16 2012-03-15 Nitrogenholdig mættet heterocyclisk forbindelse

Country Status (17)

Country Link
US (2) US9278944B2 (da)
EP (1) EP2687518B1 (da)
JP (1) JP5760078B2 (da)
KR (1) KR101651722B1 (da)
CN (1) CN103562191B (da)
AU (1) AU2012229859C1 (da)
BR (1) BR112013023480B1 (da)
CA (1) CA2828378C (da)
DK (1) DK2687518T3 (da)
ES (1) ES2652454T3 (da)
HU (1) HUE037584T2 (da)
MX (1) MX349484B (da)
PL (1) PL2687518T3 (da)
PT (1) PT2687518T (da)
RU (1) RU2595136C2 (da)
TW (1) TWI597273B (da)
WO (1) WO2012124775A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104640847B (zh) * 2012-09-14 2019-10-15 上海医药集团股份有限公司 新型肾素抑制剂
JP5764628B2 (ja) * 2012-09-14 2015-08-19 田辺三菱製薬株式会社 医薬組成物
CN113816952A (zh) * 2015-12-29 2021-12-21 上海医药集团股份有限公司 吗啉衍生物的盐及其晶型、其制备方法及药物组合物、用途
CN109705052B (zh) * 2019-01-25 2020-12-08 苏州大学 一种制备1,4-二氢噁嗪的方法
CN114129569A (zh) * 2020-09-04 2022-03-04 上海医药集团股份有限公司 一种含氮的饱和杂环化合物的应用
WO2022047730A1 (en) 2020-09-04 2022-03-10 Shanghai Pharmaceuticals Holding Co., Ltd. Methods to treat inflammatory bowel disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0119797D0 (en) * 2001-08-14 2001-10-03 Glaxo Group Ltd Chemical compounds
GB0428526D0 (en) 2004-12-30 2005-02-09 Novartis Ag Organic compounds
GB0505969D0 (en) * 2005-03-23 2005-04-27 Novartis Ag Organic compounds
DE102005017116A1 (de) * 2005-04-13 2006-10-26 Novartis Ag Hemmstoffe für Inhibitoren von Apoptose Proteinen (IAP)
GB0511063D0 (en) 2005-05-31 2005-07-06 Novartis Ag Organic compounds
TWI452044B (zh) * 2007-06-15 2014-09-11 Mitsubishi Tanabe Pharma Corp 嗎啉衍生物
US8440693B2 (en) 2009-12-22 2013-05-14 Novartis Ag Substituted isoquinolinones and quinazolinones
CN104640847B (zh) * 2012-09-14 2019-10-15 上海医药集团股份有限公司 新型肾素抑制剂

Also Published As

Publication number Publication date
KR101651722B1 (ko) 2016-08-26
EP2687518B1 (en) 2017-11-01
BR112013023480A8 (pt) 2019-07-09
TW201242955A (en) 2012-11-01
PL2687518T3 (pl) 2018-04-30
AU2012229859C1 (en) 2020-01-16
RU2013146012A (ru) 2015-05-27
MX2013010554A (es) 2013-12-02
CA2828378C (en) 2017-11-14
PT2687518T (pt) 2018-01-19
US20140011807A1 (en) 2014-01-09
US9278944B2 (en) 2016-03-08
CA2828378A1 (en) 2012-09-20
EP2687518A4 (en) 2014-08-20
BR112013023480A2 (pt) 2017-07-18
JPWO2012124775A1 (ja) 2014-07-24
ES2652454T3 (es) 2018-02-02
AU2012229859A1 (en) 2013-09-19
AU2012229859B2 (en) 2015-07-16
KR20130133294A (ko) 2013-12-06
US10155731B2 (en) 2018-12-18
US20160145220A1 (en) 2016-05-26
MX349484B (es) 2017-07-31
CN103562191B (zh) 2016-03-30
TWI597273B (zh) 2017-09-01
BR112013023480B1 (pt) 2019-10-01
EP2687518A1 (en) 2014-01-22
RU2595136C2 (ru) 2016-08-20
HUE037584T2 (hu) 2018-09-28
WO2012124775A1 (ja) 2012-09-20
CN103562191A (zh) 2014-02-05
JP5760078B2 (ja) 2015-08-05

Similar Documents

Publication Publication Date Title
CA2875877C (en) Syk inhibitors
WO2010105179A3 (en) Inhibitors of beta-secretase
EA201201377A1 (ru) Определенные аминопиридазины, композиции на их основе и способы их использования
EA201700230A1 (ru) Определенные аминопиридины, композиции на их основе и способы их применения
MX2016007861A (es) Compuestos de ácido dimetilbenzoico.
AU2012313888A8 (en) 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
RS54730B1 (sr) Inhibitori beta sekretaze
RS53503B1 (en) AMORPHIC AND CRYSTAL FORM GENZ 112638 HEMITARTARATE AS A GLYCOSILKERAMIDE SYNTHASIS INHIBITOR
EA201290632A1 (ru) Производные бетулина
RS53839B1 (en) SPIROCYCLES AS INHIBITORS OF 11-BETA HYDROXYSTEROID DEHYDROGENASE TYPE 1
AU2012236166A8 (en) Combinations of AKT inhibitor compounds and chemotherapeutic agents, and methods of use
EA201490759A1 (ru) Ингибиторы протеинкиназы
DK2687518T3 (da) Nitrogenholdig mættet heterocyclisk forbindelse
RS54526B1 (en) USE OF PIRAZOLOSPIROKETONE DERIVATIVES AS ACETYL-COA CARBOXYLASE INHIBITORS
WO2010014930A3 (en) Piperidine derivatives as jak3 inhibitors
MX355088B (es) Inhibidores de tienopirimidina de proteina cinasa c atipica.
MY152972A (en) Azabicyclo compound and salt thereof
IN2014DN07509A (da)
MX339455B (es) Inhibidores de pirimidina y topoisomerasa iv.
WO2014031872A3 (en) Small molecule inhibitors for treating parasitic infections
JO3318B1 (ar) مثبطات bace
EA200900924A1 (ru) Циклизованные производные как ингибиторы eg-5
RS53900B1 (en) CRYSTAL FORMS OF HYDROCHLORIDE SALTS (4A-R, 9A-S) -1- (1H-BENZOIMIDAZOL-5-CARBONYL) -2,3,4,4A, 9,9A-HEXAHIDRO-1H-INDENO [2,1-B] PIRIDIN-6-CARBONITRILA AND THEIR USE AS A HSD INHIBITOR 1
EA201492255A1 (ru) Феноксиэтилпиперидиновые соединения
IN2014CN04449A (da)